Jericho Assisted Living
Monday, June 27, 2016
LDL Increase With Tofacitinib: Does it Matter? (CME/CE)
(MedPage Today) -- Manufacturer's trial data suggest little effect on CV events out to 5 years
via
LDL Increase With Tofacitinib: Does it Matter? (CME/CE)
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment